Sartorius Stedim Biotech SA banner

Wall St Price Targets

SRTOY Price Forecast
Based on 17 analysts

+19% Upside
from $23.43 today

Sartorius Stedim Biotech SA (SRTOY)’s 12-month stock price forecast through October 2027 has a consensus target of $27.78, implying 19% upside. The forecast is based on price targets from 17 Wall Street analysts.

SRTOY Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for SRTOY yet.

Sartorius Stedim Biotech SA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SRTOY's stock price target?
Price Target
27.78 USD

According to Wall Street analysts, the average 1-year price target for SRTOY is 27.78 USD with a low forecast of 23.82 USD and a high forecast of 33.14 USD.

What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.

What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.

What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.

What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
34%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 34%.

What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.

Back to Top